Artificial intelligence (AI) is becoming increasingly influential in the field of ophthalmology, particularly in the realm of diagnosis and treatment. Artificial intelligence in eye care is being integrated into advanced diagnostic systems, helping ophthalmologists quickly analyze vast amounts of imaging data with improved accuracy. Machine learning algorithms are capable of detecting subtle changes in images, aiding in the early detection of diseases such as diabetic retinopathy, glaucoma, and macular degeneration. Beyond diagnostics, AI is being used in predictive analytics to better understand disease progression and tailor treatments to individual patient needs. As AI continues to evolve, its potential to transform how eye care is delivered—by enhancing diagnostic capabilities and streamlining workflow—promises a more efficient and personalized approach to patient care. The ongoing refinement of AI tools in ophthalmology could greatly reduce diagnostic errors and enhance treatment outcomes, ultimately benefiting both clinicians and patients alike.







Title : Lenadogene nolparvovec gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : Stereotactic radiotherapy for wet age-related macular degeneration: year 4 results of a randomised, double-masked, sham-controlled trial
Tim Jackson, King’s College London, United Kingdom